PLSH (Panacea Life Sciences Holdings) Ending Cash Position: $0.01 Mil (As of Sep. 2025)


PLSH Panacea Life Sciences Holdings Inc PLSH
28 GF Score
Price $0.14
! 6 Warning Signs
View Full Analysis

What is Panacea Life Sciences Holdings Ending Cash Position?

Panacea Life Sciences Holdings PLSH +4.55% 28 Ending Cash Position is $0.01 Mil as of Sep. 2025. GuruFocus rates PLSH with a GF Score™ of 28/100. The stock has 6 warning signs investors should review.

Panacea Life Sciences Holdings's Ending Cash Position for the quarter that ended in Sep. 2025 was $0.01 Mil.

Panacea Life Sciences Holdings's quarterly Ending Cash Position declined from Mar. 2025 ($0.26 Mil) to Jun. 2025 ($0.24 Mil) and declined from Jun. 2025 ($0.24 Mil) to Sep. 2025 ($0.01 Mil).

Panacea Life Sciences Holdings's annual Ending Cash Position declined from Dec. 2021 ($0.02 Mil) to Dec. 2022 ($0.01 Mil) but then increased from Dec. 2022 ($0.01 Mil) to Dec. 2023 ($0.10 Mil).

Panacea Life Sciences Holdings Ending Cash Position Related Terms

Panacea Life Sciences Holdings Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Panacea Life Sciences Holdings's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panacea Life Sciences Holdings Ending Cash Position Chart

Panacea Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Ending Cash Position
0.08 0.02 0.01 0.10

Panacea Life Sciences Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.21 0.26 0.24 0.01
PLSH
28GF Score
Panacea Life Sciences Holdings Inc PLSH
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Panacea Life Sciences Holdings Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Panacea Life Sciences Holdings's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.006+0.095
=0.10

Panacea Life Sciences Holdings's Ending Cash Position for the quarter that ended in Sep. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.445+-1.437
=0.01

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.01 Mil mean?
Panacea Life Sciences Holdings (PLSH) has a Ending Cash Position of $0.01 Mil as of Sep. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Panacea Life Sciences Holdings and its competitors.
Is Panacea Life Sciences Holdings' Ending Cash Position too high?
Panacea Life Sciences Holdings' current Ending Cash Position is $0.01 Mil. Overall, Panacea Life Sciences Holdings has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Panacea Life Sciences Holdings' Ending Cash Position compare to SKYI and IMCC?
Panacea Life Sciences Holdings' Ending Cash Position of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Panacea Life Sciences Holdings and its competitors. Panacea Life Sciences Holdings's current Ending Cash Position is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panacea Life Sciences Holdings stock overvalued right now?
Panacea Life Sciences Holdings (PLSH) has a current Ending Cash Position of $0.01 Mil. The current Ending Cash Position is $0.01 Mil. Panacea Life Sciences Holdings' overall GF Score™ is 28/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Panacea Life Sciences Holdings (PLSH), the current Ending Cash Position is $0.01 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Panacea Life Sciences Holdings Business Description

Address 5910 South University Boulevard, C18-193, Greenwood Village, CO, USA, 80121
Panacea Life Sciences Holdings Inc is a holding company organized as a plant-based natural health ingredient and product company, specializing in the development, manufacturing, research, and distribution of products and rapidly growing natural health and wellness market segment for both humans and animals. The company also offers the purest natural remedies within its branded product lines for every aspect of life: PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure and PANA Life.
28GF Score

Get the complete analysis for PLSH

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price